Rights and permissions
About this article
Cite this article
Ribavirin is the first oral drug to potentially treat chronic hepatitis C. Inpharma Wkly. 787, 1 (1991). https://doi.org/10.2165/00128413-199107870-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199107870-00001